Evidence map›Paper›PMID 23278868›Full record

ArticleAlcoholism, clinical and experimental research2013

Microinjections of acetaldehyde or salsolinol into the posterior ventral tegmental area increase dopamine release in the nucleus accumbens shell.

Gerald A Deehan, Eric A Engleman, Zheng-Ming Ding, William J McBride, Zachary A Rodd

Abstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Molecular Imaging Studies of Alcohol Use Disorder.Current topics in behavioral neurosciences · 2025
    Review
  7. Role of Metabolism on Alcohol Preference, Addiction, and Treatment.Current topics in behavioral neurosciences · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Acetaldehyde Excitation of Lateral Habenular Neurons via Multiple Cellular Mechanisms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Neuroimaging in Alcohol and Drug Dependence.Current behavioral neuroscience reports · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gerald A DeehanDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202, USA. gdeehan@iupui.edu
Eric A Engleman
Zheng-Ming Ding
William J McBride
Zachary A Rodd
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Translational Research and Science Education (OUT)P60AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI DAVID A. KAREKEN · 2003 to 2026
$45.5M
TRAINING GRANT ON GENETICS ASPECTS OF ALCOHOLISMT32AA007462 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI CRISTINE L CZACHOWSKI · 1985 to 2026
$10.7M
Ethanol and nicotine co-abuse: cross sensitization of their reinforcing actionsRC2AA019366 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI MCBRIDE, WILLIAM J · 2009 to 2010
$2.6M
Involvement of Aldehydes in Alcohol AddictionR01AA014437 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MCBRIDE, WILLIAM J · 2005 to 2009
$1.4M
NIAAA NIH HHS AA014437NIAAA NIH HHS AA019366NIAAA NIH HHS AA07462NIAAA NIH HHS P60 AA007611NIAAA NIH HHS R01 AA014437NIAAA NIH HHS RC2 AA019366NIAAA NIH HHS T32 AA007462
6 · The paper itself

Abstract

backgroundPublished findings indicate that acetaldehyde (ACD; the first metabolite of ethanol [EtOH]) and salsolinol (SAL; formed through the nonenzymatic condensation of ACD and dopamine [DA]) can be formed following EtOH consumption. Both ACD and SAL exhibit reinforcing properties within the posterior ventral tegmental area (pVTA) and both exhibit an inverted "U-shaped" dose-response curve. The current study was undertaken to examine the dose-response effects of microinjections of ACD or SAL into the pVTA on DA efflux in the nucleus accumbens shell (AcbSh).

methodsFor the first experiment, separate groups of male Wistar rats received pulse microinjections of artificial cerebrospinal fluid (aCSF) or 12-, 23-, or 90-μM ACD into the pVTA, while extracellular DA levels were concurrently measured in the AcbSh. The second experiment was similarly conducted, except rats were given microinjections of aCSF or 0.03-, 0.3-, 1.0-, or 3.0-μM SAL, while extracellular levels of DA were measured in the AcbSh.

resultsBoth ACD and SAL produced a dose-dependent inverted "U-shaped" response on DA release in the AcbSh, with 23-μM ACD (200% baseline) and 0.3-μM SAL (300% baseline) producing maximal peak responses with higher concentrations of ACD (90 μM) and SAL (3.0 μM) producing significantly lower DA efflux.

conclusionsThe findings from the current study indicate that local application of intermediate concentrations of ACD and SAL stimulated DA neurons in the pVTA, whereas higher concentrations may be having secondary effects within the pVTA that inhibit DA neuronal activity. The present results parallel the studies on the reinforcing effects of ACD and SAL in the pVTA and support the idea that the reinforcing effects of ACD and SAL within the pVTA are mediated by activating DA neurons.

Indexed as

Ventral Tegmental AreaAcetaldehydeAnimalsDopamineDopaminergic NeuronsDose-Response Relationship, DrugEthanolIsoquinolinesMaleMicrodialysisMicroinjectionsNucleus AccumbensRatsRats, WistarReinforcement, PsychologyAcetaldehydeDopamineEthanolIsoquinolinessalsolinol

Identifiers

PMID23278868
PMCPMC4265471
OpenAlexW2058634573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.